{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:55:17Z","timestamp":1791060917067,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015801","name":"Anhui Provincial Quality Engineering Project","doi-asserted-by":"publisher","award":["2023jyxm1250"],"award-info":[{"award-number":["2023jyxm1250"]}],"id":[{"id":"10.13039\/100015801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015801","name":"Anhui Provincial Quality Engineering Project","doi-asserted-by":"publisher","award":["2021jyxm1795"],"award-info":[{"award-number":["2021jyxm1795"]}],"id":[{"id":"10.13039\/100015801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2021zhyx-C20"],"award-info":[{"award-number":["2021zhyx-C20"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","award":["2021YJKJJ08"],"award-info":[{"award-number":["2021YJKJJ08"]}],"id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009076","name":"University of Science and Technology of China","doi-asserted-by":"publisher","award":["2022YJKJJ08"],"award-info":[{"award-number":["2022YJKJJ08"]}],"id":[{"id":"10.13039\/501100009076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbadis.2026.168185","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:23:29Z","timestamp":1770164609000},"page":"168185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dapagliflozin targets ROR\u03b3t to improve myocardial ischemia-reperfusion injury-induced heart failure by regulating the CD4+ T cell\/Th17 cell axis within cardiac tissue"],"prefix":"10.1016","volume":"1872","author":[{"given":"Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168185_bb0005","article-title":"Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors","author":"FDA","year":"2018"},{"issue":"21","key":"10.1016\/j.bbadis.2026.168185_bb0010","first-page":"2099","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbadis.2026.168185_bb0015","first-page":"1094","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"374","author":"Zinman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.bbadis.2026.168185_bb0020","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.bbadis.2026.168185_bb0025","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.bbadis.2026.168185_bb0030","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"NEJM"},{"issue":"12","key":"10.1016\/j.bbadis.2026.168185_bb0035","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"NEJM"},{"issue":"36","key":"10.1016\/j.bbadis.2026.168185_bb0040","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"TA","year":"2021","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.bbadis.2026.168185_bb0045","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"37","key":"10.1016\/j.bbadis.2026.168185_bb0050","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01016-5","article-title":"Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events","volume":"19","author":"Spigoni","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168185_bb0060","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvx186","article-title":"Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability","volume":"114","author":"D\u00edaz-Rodr\u00edguez","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"Pt B","key":"10.1016\/j.bbadis.2026.168185_bb0065","article-title":"SGK1 is involved in doxorubicin-induced chronic cardiotoxicity and dysfunction through activation of the NF\u03baB pathway","volume":"125","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168185_bb0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.14744\/AnatolJCardiol.2023.2825","article-title":"Dapagliflozin may protect against doxorubicin-induced cardiotoxicity","volume":"27","author":"Ulusan","year":"2023","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.bbadis.2026.168185_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104870","article-title":"Empagliflozin protects heart from inflammation and energy depletion via AMPK activation","volume":"158","author":"Koyani","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168185_bb0080","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/bib\/bby063","article-title":"A brief history of bioinformatics","volume":"20","author":"Gauthier","year":"2019","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bbadis.2026.168185_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113792","article-title":"Targeted pharmacokinetics and bioinformatics screening strategy reveals JAK2 as the main target for Xin-Ji-Er-Kang in treatment of MIR injury","volume":"155","author":"Zhou","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2026.168185_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155969","article-title":"Targeting and degradation of OTUB1 by Erianin for antimetastasis in esophageal squamous cell carcinoma","volume":"135","author":"Zhu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbadis.2026.168185_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156420","article-title":"Xin-Ji-Er-Kang balances mitochondrial fusion and fission to protect cardiomyocytes in mice with heart failure by regulating the ER\u03b1\/SIRT3 pathway","volume":"139","author":"Cai","year":"2025","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bbadis.2026.168185_bb0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2012.09.016","article-title":"A validated regulatory network for Th17 cell specification","volume":"151","author":"Ciofani","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41392-020-00455-6","article-title":"A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"Pt B","key":"10.1016\/j.bbadis.2026.168185_bb0110","article-title":"PCSK9 inhibition ameliorates experimental autoimmune myocarditis by reducing Th17 cell differentiation through LDLR\/STAT-3\/ROR-\u03b3t pathway","volume":"124","author":"Yu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168185_bb0115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/TP.0b013e31827a48f5","article-title":"Digoxin attenuates acute cardiac allograft rejection by antagonizing ROR\u03b3t activity","volume":"95","author":"Wu","year":"2013","journal-title":"TRANSPLANTATION"},{"issue":"18","key":"10.1016\/j.bbadis.2026.168185_bb0120","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168185_bb0125","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4155\/bio.10.139","article-title":"Validated LC-MS\/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma","volume":"2","author":"Aubry","year":"2010","journal-title":"Bioanalysis"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","article-title":"CB-dock: a web server for cavity detection-guided protein-ligand blind docking","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"1\u20132","key":"10.1016\/j.bbadis.2026.168185_bb0135","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2013.03.012","article-title":"Isolation and analysis of single cells from the mouse heart","volume":"393","author":"Pinto","year":"2013","journal-title":"J. Immunol. Methods"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168185_bb0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41401-023-01222-3","article-title":"Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF\/CCL2\/CCR2 and phenotype switching","volume":"45","author":"Shen","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"6141","key":"10.1016\/j.bbadis.2026.168185_bb0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Martinez Molina","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.bbadis.2026.168185_bb0150","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/etc.4800","article-title":"Moving Beyond p<0.05 in Ecotoxicology: A Guide for Practitioners","volume":"39","author":"Erickson","year":"2020","journal-title":"Environ. Toxicol. Chem."},{"issue":"9","key":"10.1016\/j.bbadis.2026.168185_bb0155","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/s41591-022-01971-4","article-title":"Dapagliflozin Across the Range of Ejection Fraction in Patients with Heart Failure: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER","volume":"28","author":"Jhund","year":"2022","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168185_bb0160","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCRESAHA.117.311588","article-title":"Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors","volume":"122","author":"Scheen","year":"2018","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cvr\/cvx149","article-title":"Cardiac effects of SGLT2 inhibitors: the sodium hypothesis","volume":"114","author":"Bertero","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0170","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01016-5","article-title":"Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events","volume":"19","author":"Spigoni","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168185_bb0175","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41401-022-00885-8","article-title":"Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1\/MAPK signaling","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/ijbs.100351","article-title":"Oncogenic RAR\u03b3 isoforms promote head and neck cancer proliferation through vinexin-\u03b2-mediated cell cycle acceleration and autocrine activation of EGFR signal","volume":"21","author":"Su","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168185_bb0185","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR gammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbadis.2026.168185_bb0190","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.cmet.2021.08.014","article-title":"Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168185_bb0195","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41401-023-01057-y","article-title":"Notoginsenoside R1 protects against myocardial ischemia\/reperfusion injury in mice via suppressing TAK1-JNK\/p38 signaling","volume":"44","author":"Zeng","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168185_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cells11101676","article-title":"Novel insights into the cardioprotective effects of calcitriol in myocardial infarction","volume":"11","author":"Yang","year":"2022","journal-title":"Cells"},{"issue":"47","key":"10.1016\/j.bbadis.2026.168185_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202205062","article-title":"Biodegradable redox-responsive AIEgen-based-covalent organic framework nanocarriers for long-term treatment of myocardial ischemia\/reperfusion injury","volume":"18","author":"Huang","year":"2022","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.bbadis.2026.168185_bb0210","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.apsb.2021.12.024","article-title":"Anticarin-\u03b2 shows a promising anti-osteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbadis.2026.168185_bb0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.05.004","article-title":"The heart of the matter: protection of the myocardium from T cells","volume":"45","author":"Lichtman","year":"2013","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.bbadis.2026.168185_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032696","article-title":"CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease","volume":"24","author":"Gomez-Bris","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168185_bb0225","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168185_bb0230","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185218","article-title":"T cells in cardiac health and disease","volume":"135","author":"Mart\u00edn","year":"2025","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.bbadis.2026.168185_bb0235","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa2003608","article-title":"A Novel Circulating MicroRNA for the Detection of Acute Myocarditis","volume":"384","author":"Blanco-Dom\u00ednguez","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0240","doi-asserted-by":"crossref","first-page":"H124","DOI":"10.1152\/ajpheart.00028.2019","article-title":"T-cell recruitment to the heart: friendly guests or unwelcome visitors?","volume":"317","author":"Blanton","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168185_bb0245","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","article-title":"A simplified, langendorff-free method for concomitant isolation of viable cardiac myocytes and nonmyocytes from the adult mouse heart","volume":"119","author":"Ackers-Johnson","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2026.168185_bb0250","series-title":"Assessment report: Forxiga (Dapagliflozin) [Public assessment report]","author":"European Medicines Agency","year":"2012"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168185_bb0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12933-022-01532-6","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion injury through improving mitochondrial homeostasis","volume":"21","author":"Zou","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168185_bb0260","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s13238-020-00809-4","article-title":"Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis","volume":"13","author":"Jiang","year":"2022","journal-title":"Protein Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:25:01Z","timestamp":1791059101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0925443926000335"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168185","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin targets ROR\u03b3t to improve myocardial ischemia-reperfusion injury-induced heart failure by regulating the CD4+ T cell\/Th17 cell axis within cardiac tissue","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168185"}}